These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. A fluorimetric assay for succinic semialdehyde dehydrogenase activity suitable for prenatal diagnosis of the enzyme deficiency. Thorburn DR; Thompson GN; Howells DW J Inherit Metab Dis; 1993; 16(6):942-9. PubMed ID: 8127070 [TBL] [Abstract][Full Text] [Related]
47. Succinic Semialdehyde Dehydrogenase Deficiency Presenting as Autism Spectrum Disorder. Gogou M; Spilioti M; Tramma D; Papadopoulou-Alataki E; Evangeliou A Indian J Pediatr; 2016 Sep; 83(9):1036-7. PubMed ID: 26806207 [No Abstract] [Full Text] [Related]
48. Prenatal diagnosis of succinate semialdehyde dehydrogenase deficiency in non-identical twins. Aligianis IA; Farndon PA; Gray RG; Heath SK; Kilby M; Gibson KM; Akaboshi S J Inherit Metab Dis; 2002 Oct; 25(6):517-8. PubMed ID: 12555945 [TBL] [Abstract][Full Text] [Related]
49. Isosterism and molecular modification in drug design: new n-dipropylacetate analogs as inhibitors of succinic semi aldehyde dehydrogenase. Kraus JL Pharmacol Res Commun; 1983 Feb; 15(2):119-29. PubMed ID: 6405398 [No Abstract] [Full Text] [Related]
50. Succinic semialdehyde dehydrogenase deficiency in children and adults. Pearl PL; Novotny EJ; Acosta MT; Jakobs C; Gibson KM Ann Neurol; 2003; 54 Suppl 6():S73-80. PubMed ID: 12891657 [TBL] [Abstract][Full Text] [Related]
51. A novel mutation of ALDH5A1 gene associated with succinic semialdehyde dehydrogenase deficiency. Lin CY; Weng WC; Lee WT J Child Neurol; 2015 Mar; 30(4):486-9. PubMed ID: 25246302 [TBL] [Abstract][Full Text] [Related]
52. Mutation analysis in a patient with succinic semialdehyde dehydrogenase deficiency: a compound heterozygote with 103-121del and 1460T > A of the ALDH5A1 gene. Aoshima T; Kajita M; Sekido Y; Ishiguro Y; Tsuge I; Kimura M; Yamaguchi S; Watanabe K; Shimokata K; Niwa T Hum Hered; 2002; 53(1):42-4. PubMed ID: 11901270 [TBL] [Abstract][Full Text] [Related]
53. Direct observation of 3-keto-valproate in urine by 2D-NMR spectroscopy. Meshitsuka S; Koeda T; Muro H Clin Chim Acta; 2003 Aug; 334(1-2):145-51. PubMed ID: 12867285 [TBL] [Abstract][Full Text] [Related]
54. Neurodevelopmental pattern of succinic semialdehyde dehydrogenase deficiency (gamma-hydroxybutyric aciduria). Philippe A; Deron J; Geneviève D; de Lonlay P; Gibson KM; Rabier D; Munnich A Dev Med Child Neurol; 2004 Aug; 46(8):564-8. PubMed ID: 15287248 [TBL] [Abstract][Full Text] [Related]
55. Biogenic aldehyde metabolism in rat brain. Differential sensitivity of aldehyde reductase isoenzymes to sodium valproate. Whittle SR; Turner AJ Biochim Biophys Acta; 1981 Jan; 657(1):94-105. PubMed ID: 6783097 [TBL] [Abstract][Full Text] [Related]
56. Increases in metabolism of valproate and excretion of 6beta-hydroxycortisol in patients with traumatic brain injury. Anderson GD; Awan AB; Adams CA; Temkin NR; Winn HR Br J Clin Pharmacol; 1998 Feb; 45(2):101-5. PubMed ID: 9491821 [TBL] [Abstract][Full Text] [Related]
57. Effects of anticonvulsants on the formation of gamma-hydroxybutyrate from gamma-aminobutyrate in rat brain. Whittle SR; Turner AJ J Neurochem; 1982 Mar; 38(3):848-51. PubMed ID: 7057198 [TBL] [Abstract][Full Text] [Related]
59. Valproic acid utilizes the isoleucine breakdown pathway for its complete β-oxidation. Luís PB; Ruiter JP; Ofman R; Ijlst L; Moedas M; Diogo L; Garcia P; de Almeida IT; Duran M; Wanders RJ; Silva MF Biochem Pharmacol; 2011 Dec; 82(11):1740-6. PubMed ID: 21843514 [TBL] [Abstract][Full Text] [Related]
60. Abnormal alterations in the metabolic patterns of patients on valproate therapy. Kreher U; Darius J; Wien F J Pharm Pharmacol; 2002 Jul; 54(7):989-95. PubMed ID: 12162719 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]